POTENZA, Leonardo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 29.270
AS - Asia 11.721
EU - Europa 10.874
SA - Sud America 1.604
Continente sconosciuto - Info sul continente non disponibili 505
AF - Africa 282
OC - Oceania 32
Totale 54.288
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 28.672
SG - Singapore 3.408
GB - Regno Unito 2.925
CN - Cina 2.838
IT - Italia 2.628
HK - Hong Kong 1.832
VN - Vietnam 1.300
BR - Brasile 1.195
SE - Svezia 1.168
DE - Germania 943
FI - Finlandia 798
RU - Federazione Russa 566
BD - Bangladesh 554
FR - Francia 469
UA - Ucraina 396
CA - Canada 311
KR - Corea 302
TR - Turchia 291
IN - India 273
ID - Indonesia 229
BG - Bulgaria 168
NL - Olanda 143
AR - Argentina 115
MX - Messico 108
IQ - Iraq 97
JP - Giappone 88
ES - Italia 81
BE - Belgio 71
PL - Polonia 71
ZA - Sudafrica 71
IE - Irlanda 69
EC - Ecuador 68
CZ - Repubblica Ceca 67
CO - Colombia 64
PK - Pakistan 63
AE - Emirati Arabi Uniti 61
AT - Austria 61
PH - Filippine 46
CL - Cile 45
LT - Lituania 44
MA - Marocco 43
KE - Kenya 41
VE - Venezuela 40
MY - Malesia 38
CR - Costa Rica 35
JM - Giamaica 34
UZ - Uzbekistan 34
SA - Arabia Saudita 31
PY - Paraguay 29
AU - Australia 28
JO - Giordania 28
IR - Iran 27
DZ - Algeria 26
AZ - Azerbaigian 23
CH - Svizzera 23
BZ - Belize 22
EG - Egitto 22
RO - Romania 22
EU - Europa 18
PT - Portogallo 17
TN - Tunisia 17
UY - Uruguay 17
AL - Albania 16
DK - Danimarca 16
SK - Slovacchia (Repubblica Slovacca) 16
IL - Israele 15
TW - Taiwan 15
BO - Bolivia 14
NP - Nepal 14
PE - Perù 13
SI - Slovenia 13
TH - Thailandia 13
TT - Trinidad e Tobago 13
EE - Estonia 12
NI - Nicaragua 12
OM - Oman 12
RS - Serbia 12
DO - Repubblica Dominicana 10
GR - Grecia 10
PR - Porto Rico 10
PS - Palestinian Territory 10
BH - Bahrain 9
GT - Guatemala 9
MK - Macedonia 9
NG - Nigeria 9
BY - Bielorussia 8
HN - Honduras 8
KG - Kirghizistan 8
KZ - Kazakistan 8
QA - Qatar 8
BN - Brunei Darussalam 7
CY - Cipro 7
LB - Libano 7
NO - Norvegia 7
SC - Seychelles 7
XK - ???statistics.table.value.countryCode.XK??? 7
ET - Etiopia 6
MD - Moldavia 6
PA - Panama 6
SN - Senegal 6
Totale 53.702
Salva come PNG Salva come JPEG
Città #
Ashburn 3.285
Fairfield 2.631
Santa Clara 2.322
Singapore 2.093
Southend 1.888
Hong Kong 1.809
Woodbridge 1.517
San Jose 1.386
Chandler 1.329
Houston 1.286
Seattle 1.051
Ann Arbor 891
Wilmington 860
Cambridge 833
Hefei 791
Council Bluffs 713
Jacksonville 666
Nyköping 664
Helsinki 606
Dearborn 591
Beijing 540
London 535
Los Angeles 500
Chicago 485
New York 474
Modena 436
Ho Chi Minh City 419
Hanoi 296
Milan 278
Seoul 276
The Dalles 272
San Diego 255
Munich 196
Buffalo 187
Salt Lake City 182
Princeton 177
Bologna 176
Jakarta 174
Lauterbourg 164
Sofia 164
Dallas 153
Eugene 135
Izmir 135
Moscow 135
Fremont 125
Shanghai 122
Columbus 118
Boardman 103
Bremen 102
São Paulo 101
Rome 99
Orem 98
Phoenix 91
Tampa 82
Toronto 82
Frankfurt am Main 80
Atlanta 73
Da Nang 72
Elk Grove Village 71
Redwood City 66
Des Moines 62
Dublin 61
Tokyo 61
Montreal 59
Brooklyn 57
Brussels 55
Denver 55
Nuremberg 55
Reggio Emilia 55
Warsaw 54
Turku 53
Chennai 52
Miami 52
Haiphong 50
Philadelphia 44
Boston 41
Las Vegas 41
Guangzhou 40
Mexico City 40
Nairobi 39
Amsterdam 38
Dong Ket 38
Parma 38
Stockholm 38
San Francisco 37
Lancaster 36
Sterling 36
Vienna 36
Baghdad 35
Johannesburg 34
Kent 34
Naples 34
Ottawa 34
Redondo Beach 33
Manchester 32
Washington 32
Detroit 31
Rio de Janeiro 31
Paris 30
Tashkent 30
Totale 37.154
Salva come PNG Salva come JPEG
Nome #
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 490
HHV-6A in syncytial giant-cell hepatitis 483
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 456
B cells and herpesviruses: a model of lymphoproliferation 456
Kaposi's sarcoma after liver transplantation 456
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 453
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 432
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 423
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 418
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 408
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 397
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 392
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 387
Mucorales-specific T cells in patients with hematologic malignancies 383
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 383
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 380
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 377
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 374
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 373
Translational challenges of human herpesvirus 6 chromosomal integration. 369
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 368
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 367
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 366
Acute appendicitis in adult neutropenic patients with hematologic malignancies 365
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 364
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 361
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 360
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 360
Early versus delayed palliative/supportive care in advanced cancer: An observational study 360
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 357
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 355
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 355
Leukaemic pulmonary infiltrates in adult acute myeloid leukaemia: a high-resolution computerized tomography study 353
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 352
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 350
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 349
Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma 348
T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature 348
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 347
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 344
invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 341
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 338
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 337
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 336
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 335
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 333
Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience 331
Rhodotorula infection in haematological patient: risk factors and outcome 328
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 326
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 326
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 324
Parvoviruses in blood donors and transplant patients, Italy 324
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 321
Investigating the association between physicians self-efficacy regarding communication skills and risk of “burnout” 321
A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura. 319
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 317
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 314
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 314
Diagnosis of aspergillosis: Role of proteomics 314
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 312
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 311
Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study) 310
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 308
Breast Location for De Novo Extramedullary Myeloid Sarcoma 308
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 307
Different semantic and affective meaning of the words associated to physical and social pain in cancer patients on early palliative/supportive care and in healthy, pain-free individuals 305
Veicolazione liposomiale del cidofovir nel trattamento del PEL (Primary Effusion Lynphoma) 302
Ruxolitinib for pulmonary extramedullary hematopoiesis in myelofibrosis 301
"Metodo per la diagnosi e/o il monitoraggio della mucormicosi" - "Method for the diagnosis of and/or monitoring mucormycosis" 300
Identification and characterization of Aspergillus-specific immune responses to diagnose invasive aspergillosis in high risk patients: a multicenter study 299
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 298
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 298
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 295
Circulating functional T cells specific to human herpes virus 6 (HHV6) antigens in individuals with chromosomally integrated HHV6 295
May the indirect effects of CIHHV-6 in transplant patients be exerted through the reactivation of the viral replicative machinery? 295
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 294
'Gloves and socks' papular purpuric syndrome following primary infection with parvovirus B19: a link between dermatologists and haematologists 292
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 291
The importance of cytogenetic and molecular analyses in eosinophilia-associated myeloproliferative neoplasms: an unusual case with normal karyotype and TNIP1- PDGFRB rearrangement and overview of PDGFRB partner genes 290
Myocardial ischemia in a patient with acute lymphoblastic leukemia during L-asparaginase therapy 290
Common vascular endothelial growth factor variants and risk for posttransplant Kaposi sarcoma. 289
HHV-6 and atypical lymphoproliferative disorders: are only qualitative molecular examinations sufficient to support a pathogenetic role? 289
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 289
Multicenter Prospective Study for Laboratory Diagnosis of HHV8 Infection in Solid Organ Donors and Transplant Recipients and Evaluation of the Clinical Impact After Transplantation 288
Treatment of herpesvirus associated primary effusion lymphoma with intracavity cidofovir 286
Pain and emotional distress in leukemia patients at diagnosis. 285
BTK Inhibitors Impair Platelet-Mediated Antifungal Activity 285
Use of a high sensitive nanofluidic array for the detection of rare copies of BCR-ABL1 transcript in patients with Philadelphia-positive acute lymphoblastic leukemia in complete response 284
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 280
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 280
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 279
Prevalence of Human Herpesvirus-6 Chromosomal Integration (CIHHV-6) in Italian Solid Organ and Allogeneic Stem Cell Transplant Patients 278
Indirect Antitumor Effects of Mammalian Target of Rapamycin Inhibitors Against Kaposi Sarcoma in Transplant Patients 274
How I treat HHV8/KSHV-related diseases in posttransplant patients. 272
BK virus infection and neurologic dysfunctions in a patient with lymphoma treated with chemotherapy and rituximab 272
Role of Notch2 pathway in mature B cell malignancies 271
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 271
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 269
Mucorles-specific T cells emerge in the course of invasive mucormucosis and may be used as a surrogate diagnostic marker in high-risk patients 268
Metodo per la diagnosi e/o il monitoraggio dell’ aspergillosi invasiva 266
Totale 33.494
Salva come PNG Salva come JPEG
Categoria #
all - tutte 220.132
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 220.132
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.683 0 0 0 185 85 173 203 181 349 315 622 570
2022/20234.019 510 454 278 366 545 502 105 429 429 74 167 160
2023/20242.910 102 141 189 267 527 275 313 437 59 90 185 325
2024/20258.829 294 120 157 574 1.524 1.252 628 483 1.254 482 908 1.153
2025/202616.999 1.231 634 1.263 1.851 2.680 1.171 2.188 789 1.634 1.459 1.237 862
2026/20273.026 495 998 1.084 449 0 0 0 0 0 0 0 0
Totale 54.288